Several lines of evidence have demonstrated that a reduction of BACE1 resulted in decreased Aβ production in several mouse models of AD (Kim et al., 2018[19]; Cai et al., 2012[4]; Xue et al, 2015[48]). This evidence concerns the gene BACE1 and Alzheimer disease.